Featured Research

from universities, journals, and other organizations

More proof that withholding HIV treatments led to thousands of deaths in South Africa

Date:
January 19, 2010
Source:
Springer Science+Business Media
Summary:
Scientists have provided additional proof that withholding HIV treatments with proven benefits led to the death of 330,000 people in South Africa as the result of AIDS denialist policies.

Despite irrefutable proof that HIV treatments have proven benefits, AIDS denialists continue to deny their value. In a paper just published online in Springer's journal AIDS and Behavior, Professor Myron Essex and Dr. Pride Chigwedere, from the Harvard School of Public Health AIDS Initiative in the US, provide additional proof that withholding HIV treatments with proven benefits led to the death of 330,000 people in South Africa as the result of AIDS denialist policies.

They also show that the harm has not been reversed and highlight that when denialism enters public health practice, as in South Africa, the consequences are disastrous.

AIDS denialists refute that HIV causes AIDS, that antiretroviral drugs are useful, and lastly, that millions of people worldwide have died from AIDS. AIDS denialists represent a growing movement that has considerable visibility on the Internet. Despite their views, it is estimated that from 2000 to 2005, at least 330,000 South Africans died prematurely and 35,000 babies were infected with HIV as a result of former president Thabo Mbeki's decision to withhold antiretroviral drugs, based on advice from American AIDS denialists.

In their thought-provoking paper, Essex and Chigwedere review the potent effects of HIV treatments and their missed opportunities in South Africa. They respond persuasively to AIDS denialist arguments with robust scientific evidence. They also discuss the key implications of the relationship between AIDS denialism and public health practice, using South Africa as the example. Finally, they argue for accountability for the human rights violations and loss of hundreds of thousands of lives, as well as the need to reform public health practice to include standards and accountability.

The authors conclude: "There is a need for honesty and peer review in situations that impact public health policy. When AIDS denialism enters public health practice, the consequences are tragic. The implications start in honest science but extend to the need for accountability and, perhaps, public health reform."


Story Source:

The above story is based on materials provided by Springer Science+Business Media. Note: Materials may be edited for content and length.


Journal Reference:

  1. Chigwedere P, Essex M. AIDS Denialism and Public Health Practice. AIDS and Behavior, 2010; DOI: 10.1007/s10461-009-9654-7

Cite This Page:

Springer Science+Business Media. "More proof that withholding HIV treatments led to thousands of deaths in South Africa." ScienceDaily. ScienceDaily, 19 January 2010. <www.sciencedaily.com/releases/2010/01/100118132134.htm>.
Springer Science+Business Media. (2010, January 19). More proof that withholding HIV treatments led to thousands of deaths in South Africa. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2010/01/100118132134.htm
Springer Science+Business Media. "More proof that withholding HIV treatments led to thousands of deaths in South Africa." ScienceDaily. www.sciencedaily.com/releases/2010/01/100118132134.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins